Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19
Completed · Not applicable
Conditions studied: COVID-19
In brief
The objective of this study is to determine the safety, feasibility and efficacy of a bidirectional oxygenation Positive End Expiratory Pressure (PEEP) mouthpiece in coronavirus disease 2019 (COVID-19) patients requiring supplemental oxygen by non-rebreather mask.
Key facts
- Study ID
- NCT04331366
- Run by
- Emory University
- People needed
- 2
- Starts
- 2020-04-08
- Expected to finish
- 2020-08-31
- Last updated by the study team
- 2021-02-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- COVID-19 positive
- Oxygen saturation <92%
- Able to provide informed consent
- Receiving oxygen by non-rebreather mask
- Not currently requiring intubation
You may not qualify if…
- Unable or unwilling to provide informed consent
- Cognitive impairment
- Rapidly decompensating status requiring urgent or emergent higher level of care
Where it is running
- Emory University Hospital — Atlanta, Georgia, United States
- Emory St. Joseph's Hospital — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.